Healthy Skepticism Library item: 16970

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Report

Families USA
The Choice: Health Care for People or Drug Industry Profits
2005 Sep
http://www.familiesusa.org/assets/pdfs/The-Choice.pdf

Abstract:

KEY FINDINGS
This report examines data from the top seven U.S.-based pharmaceutical
companies, with combined 2004 revenues of more than $190 billion. In order of
size (based on 2004 revenue), these companies are: Pfizer Inc.; Johnson &
Johnson; Merck & Co., Inc.; Abbott Laboratories; Bristol-Myers Squibb Company;
Wyeth; and Eli Lilly and Company..5
Profits (Net Income)
In 2004, these seven drug companies together reported over $34 billion
in profits. (See Table 1 and Appendix II for details on each company.)

• Pfizer reported profits of over $11 billion, which represented 22 percent
  of the company’s reported revenue.
• Johnson & Johnson reported over $8.5 billion in profits.
• Wyeth, which reported the “lowest” profits, still had profits of more
  than $1 billion.
  Table 1
  2004 Financials for U.S. Pharmaceutical Companies within the Top 200 U.S. Corporations

Source: The 2004 SEC form 10-K for each company.
1 Dollars in millions.
2 Marketing, advertising, and administration for Bristol-Myers is the sum of two line items: “Marketing, Selling, and Administrative” and “Advertising and Product Promotion”; the other companies report marketing and advertising spending together.